Table 3 Distribution of patients by REVEAL risk categories at baseline and ≥ 6-month time points in patients on macitentan
| ≥6-month | ||||||
|---|---|---|---|---|---|---|
| Baseline | 1–7 | 8 | 9 | 10–11 | ≥12 | Total |
| 1–7 | 12 | 2 | 0 | 0 | 0 | 14 |
| 8 | 5 | 2 | 3 | 0 | 0 | 10 |
| 9 | 3 | 3 | 6 | 0 | 0 | 12 |
| 10–11 | 4 | 4 | 3 | 5 | 1 | 17 |
| ≥12 | 1 | 0 | 1 | 2 | 0 | 4 |
| Total | 25 | 11 | 13 | 7 | 1 | 57 |
